[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 43,318
Sort by:

2014 Opportunities in the US Hematology and Flow Cytometry Markets

US$ 7,880.00

... . Comprehensive lists of companies developingor marketing new technologies and products by test. Strategic Recommendations New product development opportunities with significant market appeal. Alternative market penetration strategies. Potential market entry barriers and risks. Contains 275 pages and ...

November 2013 275 pages

2014 Opportunities in the European Microbiology Testing Market

US$ 15,760.00

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. “2014 Analysis of the Microbiology Testing in Europe” is a new five-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report ...

November 2013 1600 pages

2014 Opportunities in the Global Cell Surface Testing Market

US$ 4,280.00

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both ...

November 2013 120 pages

2014 Opportunities in the French Hemostasis Diagnostic Testing Market

US$ 4,880.00

... suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years. The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well ...

November 2013 405 pages

2014 Opportunities in the German Hemostasis Diagnostic Testing Market

US$ 4,880.00

... suppliers and potential market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years. The report explores business and technological trends in the German coagulation testing market; provides estimates of the test volume, as well ...

November 2013 406 pages

2014 Opportunities in the Italian Hemostasis Diagnostic Testing Market

US$ 4,880.00

... suppliers and potential market entrants identify and evaluate business opportunities emerging in the Italian coagulation testing market during the next five years. The report explores business and technological trends in the Italian coagulation testing market; provides estimates of the test volume, as well ...

November 2013 402 pages

2014 Opportunities in the Japanese Hemostasis Diagnostic Market

US$ 5,920.00

... and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years. The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well as ...

November 2013 402 pages

2014 Opportunities in the Spanish Hemostasis Diagnostic Testing Market

US$ 4,880.00

... suppliers and potential market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years. The report explores business and technological trends in the Spanish coagulation testing market; provides estimates of the test volume, as well ...

November 2013 400 pages

2014 Opportunities in the UK Hemostasis Diagnostic Testing Market

US$ 4,880.00

... lists of companies developing or marketing new technologies and products by test. Strategic Recommendations Product development and business expansion opportunities with significant market appeal. “Ideal” product models with tentative prices and operating characteristics. Alternative market penetration ...

November 2013 409 pages

2014 Opportunities in the US Hemostasis Diagnostic Testing Market

US$ 7,680.00

... lists of companies developing or marketing new technologies and products by test. Strategic Recommendations Product development and business expansion opportunities with significant market appeal. “Ideal” product models with tentative prices and operating characteristics. Alternative market penetration ...

November 2013 424 pages

2014 Opportunities in the French Flow Cytometry Market

US$ 3,120.00

... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...

November 2013 146 pages

2014 Opportunities in the German Flow Cytometry Market

US$ 3,120.00

... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...

November 2013 147 pages

2014 Opportunities in the Italian Flow Cytometry Market

US$ 3,120.00

... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...

November 2013 142 pages

2014 Opportunities in the Japanese Flow Cytometry Market

US$ 3,920.00

... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...

November 2013 142 pages

2014 Opportunities in the Spanish Flow Cytometry Market

US$ 3,120.00

... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...

November 2013 140 pages

2014 Opportunities in the UK Flow Cytometry Market

US$ 3,120.00

... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...

November 2013 146 pages

2014 Opportunities in the US Flow Cytometry Market

US$ 5,360.00

... leading reagent and instrument suppliers. Review of current and emerging diagnostic technologies, and their potential market applications. Product development opportunities for new instruments, consumables, and auxiliary products. Profiles of current and emerging suppliers, including their sales, product ...

November 2013 174 pages

2014 Analysis of Sexually-Transmitted Diseases in France: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the French STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

November 2013 280 pages

2014 Analysis of Sexually-Transmitted Diseases in Germany: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

November 2013 280 pages

2014 Analysis of Sexually-Transmitted Diseases in Italy: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test ...

November 2013 280 pages

2014 Analysis of Sexually-Transmitted Diseases in Japan: Market Outlook and Emerging Opportunities

US$ 1,920.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test ...

November 2013 280 pages

2014 Analysis of Sexually-Transmitted Diseases in Spain: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...

November 2013 280 pages

2014 Analysis of Sexually-Transmitted Diseases in the UK: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

November 2013 280 pages

2014 Analysis of Sexually-Transmitted Diseases in the US: Market Outlook and Emerging Opportunities

US$ 2,760.00

About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and ...

November 2013 280 pages

2014 Analysis of Transfusion Diagnostic Instrumentation and Strategic Profiles of Leading Suppliers

US$ 2,800.00

This new 68-page report from Venture Planning Group reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic ...

November 2013 68 pages

2014 Analysis of Enteric Diseases in France: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Germany: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Italy: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Japan: Market Outlook and Emerging Opportunities

US$ 2,080.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in Spain: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in the UK: Market Outlook and Emerging Opportunities

US$ 1,760.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Enteric Diseases in the US: Market Outlook and Emerging Opportunities

US$ 3,080.00

About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...

November 2013 322 pages

2014 Analysis of Respiratory Diseases in France: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 282 pages

2014 Analysis of Respiratory Diseases in Germany: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 283 pages

2014 Analysis of Respiratory Diseases in Italy: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

November 2013 281 pages

2014 Analysis of Respiratory Diseases in Japan: Market Outlook and Emerging Opportunities

US$ 1,920.00

About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

November 2013 282 pages

2014 Analysis of Respiratory Diseases in Spain: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report ...

November 2013 281 pages

2014 Analysis of Respiratory Diseases in the UK: Market Outlook and Emerging Opportunities

US$ 1,560.00

About This Report This new 281-page report from Venture Planning Group presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 281 pages

2014 Analysis of Respiratory Diseases in the US: Market Outlook and Emerging Opportunities

US$ 2,880.00

About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...

November 2013 283 pages

2014 Analysis of the French Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 508 pages, 67 tables and presents a comprehensive analysis of the French hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 508 pages

2014 Analysis of the German Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the German hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 523 pages

2014 Analysis of the Italian Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 521 pages, 63 tables and presents a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 521 pages

2014 Analysis of the Japanese Hospital Clinical ChemistryAnd Immunodiagnostics Market

US$ 3,880.00

This new report from Venture Planning Group contains 520 pages, 64 tables and presents a comprehensive analysis of the Japanese hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 520 pages

2014 Analysis of the Spanish Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 514 pages, 63 tables and presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic hospital laboratory practice, as ...

November 2013 514 pages

2014 Analysis of the UK Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 3,080.00

This new report from Venture Planning Group contains 523 pages, 64 tables and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...

November 2013 523 pages

2014 Analysis of the US Hospital Clinical Chemistry and Immunodiagnostics Market

US$ 6,240.00

This new report from Venture Planning Group contains 543 pages, 63 tables and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key ...

November 2013 543 pages

2014 Analysis of the US Hospital Infectious Disease Testing Market

US$ 5,440.00

This new report from Venture Planning Group contains 997 pages, 87 tables and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 997 pages

2014 Analysis of the French Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 897 pages, 77 tables and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 897 pages

2014 Analysis of the German Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 897 pages, 74 tables and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and ...

November 2013 897 pages

2014 Analysis of the Italian Hospital Infectious Disease Testing Market

US$ 3,560.00

This new report from Venture Planning Group contains 887 pages, 72 tables and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social ...

November 2013 887 pages

Filters

Search

Categories

675
84
1,065
33,609
152
69
819
657
1,866
4,252
70

Publishers

1
8
9
36
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
45
11
78
1
14
2
22
3
74
41,216
1
40
2
17
15
24
85
6
10
51
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
16,410
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

34
6
1
15
84